1. Home
  2. CUBI vs LMAT Comparison

CUBI vs LMAT Comparison

Compare CUBI & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUBI
  • LMAT
  • Stock Information
  • Founded
  • CUBI 1994
  • LMAT 1983
  • Country
  • CUBI United States
  • LMAT United States
  • Employees
  • CUBI N/A
  • LMAT N/A
  • Industry
  • CUBI Major Banks
  • LMAT Medical/Dental Instruments
  • Sector
  • CUBI Finance
  • LMAT Health Care
  • Exchange
  • CUBI Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • CUBI 1.4B
  • LMAT 2.0B
  • IPO Year
  • CUBI 2012
  • LMAT 2006
  • Fundamental
  • Price
  • CUBI $46.46
  • LMAT $89.08
  • Analyst Decision
  • CUBI Buy
  • LMAT Buy
  • Analyst Count
  • CUBI 8
  • LMAT 6
  • Target Price
  • CUBI $63.86
  • LMAT $92.60
  • AVG Volume (30 Days)
  • CUBI 290.2K
  • LMAT 98.3K
  • Earning Date
  • CUBI 10-31-2024
  • LMAT 10-31-2024
  • Dividend Yield
  • CUBI N/A
  • LMAT 0.72%
  • EPS Growth
  • CUBI 33.08
  • LMAT 47.83
  • EPS
  • CUBI 7.41
  • LMAT 1.67
  • Revenue
  • CUBI $722,462,000.00
  • LMAT $205,621,000.00
  • Revenue This Year
  • CUBI N/A
  • LMAT $15.01
  • Revenue Next Year
  • CUBI $11.71
  • LMAT $9.07
  • P/E Ratio
  • CUBI $6.12
  • LMAT $54.11
  • Revenue Growth
  • CUBI 25.87
  • LMAT 16.06
  • 52 Week Low
  • CUBI $38.69
  • LMAT $45.96
  • 52 Week High
  • CUBI $68.49
  • LMAT $93.32
  • Technical
  • Relative Strength Index (RSI)
  • CUBI 48.18
  • LMAT 55.00
  • Support Level
  • CUBI $44.31
  • LMAT $84.69
  • Resistance Level
  • CUBI $47.11
  • LMAT $92.84
  • Average True Range (ATR)
  • CUBI 1.57
  • LMAT 2.05
  • MACD
  • CUBI 0.05
  • LMAT -0.07
  • Stochastic Oscillator
  • CUBI 28.96
  • LMAT 75.21

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: